Found 0 matching trials
Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics
PHASE1To investigate the effect of four single oral doses of BIA 6-512 (25 mg, 50...
Location
Human Pharmacology Unit (UFH)
REALITY MONITORING AND DOPAMINE
NAReality-monitoring characterizes the ability to determine whether informati...
Location
Centre Hospitalier le Vinatier
Mucuna Pruriens Therapy in Parkinson's Disease
PHASE2In low-income areas worldwide, most patients with Parkinson's disease (PD) ...
Location
Clinica Niño Jesus
Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide
PHASE1The purpose of this study is to determine the effect of three single oral d...
Location
Human Pharmacology Unit
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
PHASE3The primary objective of this study was to demonstrate that Rotigotine tran...
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics
PHASE1The purpose of the study was to To investigate whether the administration o...
Location
Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers
PHASE4A group of 24 healthy volunteers receive one tablet of an association of le...
Location
Multiple Locations
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
PHASE4The purpose of this study is to determine whether levodopa/benserazide disp...
Location
Samsung Medical Center